In the past year FDA approvals of treatments for dry eye and neurotrophic keratitis are among the most read cornea-related news on Healio.com/OSN.
Here are the year’s top five cornea articles:
FDA approves Bausch + Lomb's Lumify for treatment of eye redness
The FDA approved Bausch + Lomb’s Lumify as the first over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness. Read more.
FDA approves Oxervate, the first drug to treat neurotrophic keratitis
Oxervate, cenegermin, developed by Dompé farmaceutici SpA, is the first
Uncategorized